Caffeine stimulates amyloid β-peptide release from β-amyloid precursor protein-transfected HEK293 cells

Journal of Neurochemistry

Volumn 69, Issue 4, 1997, Pages 1580-1591

  Querfurth, Henry W ^a   Jiang, Jinwei ^a   Geiger, Jonathan D ^c   Selkoe, Dennis J ^b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alzheimer's disease; Amyloid Peptide; Caffeine; HEK293 cells; Inclusion body myositis; Amyloid precursor protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CAFFEINE; CALCIUM CHANNEL; RYANODINE; RYANODINE RECEPTOR;

AGING; ALZHEIMER DISEASE; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; INCLUSION BODY MYOSITIS; NERVE CELL DEGENERATION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0030987603     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69041580.x     Document Type: Article

References (104)

1. Askanas V., Alvarez R., and Engel W. (1993) β-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann. Neurol. 34, 551-560.
2. Baudier J. and Cole R. D. (1987) Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J. Biol. Chem. 262, 17577-17583.
3. Berridge M. J. (1993) Inositol trisphosphate and calcium signalling. Nature 361, 315-325.
4. Bliss T. and Collingridge G. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
5. Bodensteiner J. and Engel A. (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies. Neurology 28, 439-446.
6. Bowman E. J., Siebers A., and Altendorf K. (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA 85, 7972-7976.
7. 2+ channel in rat cerebellum is inhibited by caffeine. Biochem. J. 282, 309-312.
8. Buxbaum J. D., Ruefo A. A., Parker C. A., Cypress A. H., and Greengard P. (1994) Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. USA 91, 4489-4493.
9. 2+ release channel. J. Biol. Chem. 262, 6460-6463.
10. Caporaso G. L., Gandy S. E., Buxbaum J. D., and Greengard P. (1992) Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 2252-2256.
11. Caporaso G., Takei K., Gandy S., Matteoli M., Mundigl O., Greengard P., and De Camilli P. (1994) Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer β/A4 amyloid precursor protein. J. Neurosci. 14, 3122-3138.
12. Chanat E. and Huttner W. (1991) Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network. J. Cell Biol. 115, 1505-1519.
13. Chavis P., Fagni L., Lansman J., and Bockaert J. (1996) Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature 382, 719-722.
14. Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., and Selkoe D. J. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation. Proc. Natl. Acad. Sci. USA 91, 11993-11997.
15. Citron M., Diehl T., Gordon G., Biere A., Seubert P., and Selkoe D. (1996) Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93, 13170-13175.
16. Citron M., Westaway D., Xia W., Carlson G., Diehl T., et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72.
17. Cras P., Kawai M., Lowery D., Gonzalez-DeWhitt P., Greenberg B., and Perry G. (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc. Natl. Acad. Sci. USA 88, 7552-7556.
18. 2+-dependent currents in cultured rat dorsal root ganglion neurones by a sperm factor and cyclic ADP-ribose. Mol. Biol. Cell 3, 1415-1425.
19. 2+ mobilizing activities of cyclic ADP-ribose and inositol triphosphate. Cell Regul. 1, 279-290.
20. De Strooper B., Umans L., Van Leuven F., and Van Den Berghe H. (1993) Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein: cleavage of APP occurs in a late compartment of the default secretion pathway. J. Cell Biol. 121, 295-304.
21. Dovey H., Suomensaari-Chrysler S., Lieberburg I., Sinha S., and Keim P. (1993) Cells with a familial Alzheimer's disease mutation produce authentic β-peptide. Neuroreport 4, 1039-1042.
22. Endo M. (1977) Calcium release from the sarcoplasmic reticulum. Physiol. Rev. 57, 71-108.
23. Esch F. S., Keim P. S., Geattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., and Ward P. J. (1990) Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 248, 1122-1124.
24. Feng L., Pereira B., and Kraus-Friedman N. (1992) Different localization of inositol 1,4,5-triphosphate and ryanodine binding sites in rat liver. Cell Calcium 13, 79-87.
25. Fleischer S. and Inui M. (1989) Biochemistry and biophysics of excitation-contraction coupling. Annu. Rev. Biophys. Biophys. Chem. 18, 333-364.
26. Flucher B. (1992) Structural analysis of muscle development: transverse tubules, sarcoplasmic reticulum, and the triad. Dev. Biol. 154, 245-260.
27. Frackowiak J., Zoltowska A., and Wisniewski H. M. (1994) Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 53, 637-645.
28. i. J. Physiol. (Lond.) 450, 217-246.
29. Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M., and Mattson M. P. (1996) Increased activity-regulating and neuroprotective efficacy of α-secretase-derived amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896.
30. Gearing M., Mon H., and Mirra S. (1996) Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann. Neurol. 39, 395-399.
31. Gravina S. A., Ho L., Eckman C. B., Long K. E., Otvos L. J., Younkin L. H., Suzuki N., and Younkin S. G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J. Biol. Chem. 270, 7013-7016.
32. Greenamyre J. T. and Young A. B. (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging 10, 593-602.
33. Haass C. and Selkoe D. J. (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75, 1039-1042.
34. Haass C., Hung A. Y., and Selkoe D. J. (1991) Processing of β-amyloid precursor protein in microglia and astrocytes favors a localization in internal vesicles over constitutive secretion. J. Neurosci. 11, 3783-3793.
35. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., and Selkoe D. J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
36. Haass C., Hung A. Y., Schlossmacher M. G., Teplow D. B., and Selkoe D. J. (1993) β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021-3024.
37. + ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type β-amyloid precursor protein. J. Biol. Chem. 270, 6186-6192.
38. Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., and Selkoe D. J. (1995b) β-Secretase cleavage of β-amyloid precursor protein with the Swedish mutation occurs within the secretory pathway after the trans-Golgi network. Nat. Med. 1, 1291-1302.
39. Hakamata Y., Nakai J., Takeshima H., and Imoto K. (1992) Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett. 312, 229-235.
40. 2+ influx in human T lymphocytes. Mol. Biol. Cell 4, 173-184.
41. Higaki J., Quon D., Zhong Z., and Cordell B. (1995) Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron 14, 651-659.
42. Hisayama T., Takayanagi I., and Okamoto Y. (1990) Ryanodine reveals multiple contractile and relaxant mechanisms in vascular smooth muscle: simultaneous measurements of mechanical activity and of cytoplasmic free calcium level with fura-2. Br. J. Pharmacol. 100, 677-684.
43. Hung A. Y., Haass C., Nitsch R. M., Qiu W. Q., Citron M., Wurtman R. J., Growdon J. H., and Selkoe D. J. (1993) Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J. Biol. Chem. 268, 22959-22962.
44. 2+-permeable pore of the calcium release channel. J. Biol. Chem. 262, 16636-16643.
45. 2+ mobilizing mechanisms in cultured rat cerebellar granule cells. J. Physiol. (Lond.) 456, 667-680.
46. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and Ihara Y. (1994) Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies: evidence that an initially deposited Aβ species is Aβ1-42(43). Neuron 13, 45-53.
47. Jarrett J. T., Berger E. P., and Lansbury P. T. Jr. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
48. Kawai M., Kalaria R., Cras P., Siedlak S., Velasco M., Shelton E., Chan H., Greenberg B., and Perry G. (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer's disease. Brain Res. 623, 142-146.
49. Koh J.-Y., Yang L. L., and Cotman C. W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320.
50. Koo E. H. and Squazzo S. (1994) Evidence that production and release of amyloid β-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389.
51. Lippincott-Schwartz J., Yuan L. C., Bonifacino J. S., and Klausner R. D. (1989) Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from the Golgi to ER. Cell 56, 801-813.
52. Louzao M., Ribeiro C., Bird G. St. J., and Putney J. (1996) Cell type specific modes of feedback regulation of capacitative calcium entry. J. Biol. Chem. 271, 14807-14813.
53. Maggio J. E., Stimson E. R., Ghilardi J. R., Allen C. J., Dahl C. E., Whitcomb D. C., Vigna S. R., Vinters H. V., Labenski M. E., and Mantyh P. W. (1992) Reversible in vitro growth of Alzheimer's disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc. Natl. Acad. Sci. USA 89, 5462-5466.
54. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
55. Masters C. L., Multhaup G., Simms G., Pottigiesser J., Martins R. N., and Beyreuther K. (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4, 2757-2763.
56. Mattson M. P., Engle M. G., and Rychlik B. (1991) Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons. Mol. Chem. Neuropathol. 15, 117-142.
57. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-414.
58. 2+ release channel. J. Biol. Chem. 268, 13765-13768.
59. McPherson P., Kim Y., Valdivia H., Knudson C., Tekekura H., Armstrong C., Coronado R., and Campbell K. (1991) The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron 7, 17-25.
60. 2+ release channel of the sarcoplasmic reticulum. J. Biol. Chem. 261, 6300-6306.
61. Mendell T., Sahenk Z., Gales T., and Paul L. (1991) Amyloid filaments in inclusion body myositis. Arch. Neural. 48, 1229-1234.
62. Nehlig A., Daval J., and Debry G. (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Rev. 17, 139-170.
63. Nitsch R. M., Slack B. E., Wurtman R. J., and Growdon J. H. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
64. Oda K. (1992) Calcium depletion blocks proteolytic cleavages of plasma protein precursors which occur at the Golgi and/or trans-Golgi network. J. Biol. Chem. 267, 17465-17471.
65. Ogawa Y. (1994) Role of ryanodine receptors. Crit. Rev. Biochem. Mol. Biol. 29, 229-274.
66. Oltersdorf T., Ward P. J., Henriksson T., Beattie E. C., Neve R., Lieberburg I., and Fritz L. C. (1990) The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J. Biol. Chem. 265, 4492-4497.
67. Pestronk A., Parhad I., Drachman D., and Price D. (1982) Membrane myopathy: morphological similarities to Duchenne muscular dystrophy. Muscle Nerve 5, 209-214.
68. Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
69. Podlisny M. B., Tolan D., and Selkoe D. J. (1991) Homology of the amyloid β-protein precursor in monkey and human supports a primate model for β-amyloidosis in Alzheimer's disease. Am. J. Pathol. 138, 1423-1435.
70. Pozzan T., Rizzuto R., Volpe P., and Meldolesi J. (1994) Molecular and cellular physiology of intracellular calcium stores. Physiol. Rev. 74, 595-636.
71. Querfurth H. W. and Selkoe D. J. (1994) Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 33, 4550-4561.
72. Reddy R., Smith D., Wayman G., Wu Z., Villacres E., and Storm D. (1995) Voltage-sensitive adenyl cyclase activity in cultured neurons. J. Biol. Chem. 270, 14340-14346.
73. Sambamurti K., Shioi J., Anderson J. P., Pappolla M. A., and Robakis N. K. (1992) Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J. Neurosci. Res. 33, 319-329.
74. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., et al. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
75. Selkoe D. J., Podlisny M. B., Joachim C. L., Vickers E. A., Lee G., Fritz L. C., and Oltersdorf T. (1988) β-Amyloid precursor protein of Alzheimer disease occurs as 110-135 kilodalton membrane-associated proteins in neural and nonneural tissues. Proc. Natl. Acad. Sci. USA 85, 7341-7345.
76. 2+ release channels in rat brain. J. Neurosci. 13, 3051-3063.
77. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X., McKay D. M., Tintner R., Frangione B., and Younkin S. G. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
78. Shorte S., Collingridge G., Randall A., Chappell J., and Schofield J. (1991) Ammonium ions mobilize calcium from an internal pool which is insensitive to TRH and ionomycin in bovine anterior pituitary cells. Cell Calcium 12, 301-312.
79. Siesjö B. K., Bengtsson F., and Grampp W. (1989) Calcium, excito-toxins, and neuronal death in the brain. Ann. NY Acad. Sci. 568, 234-290.
80. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., and Price D. L. (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495.
81. Sitia R. and Meldolesi J. (1992) Endoplasmic reticulum: a dynamic patchwork of specialized subregions. Mol. Biol. Cell 3, 1067-1072.
82. Sorrentino V. and Volpe P. (1993) Ryanodine receptors: how many, where and why? Trends Pharmacol. Sci. 14, 98-103.
83. 3H]ryanodine binding sites in postmortem human brain: regional distribution and effects of calcium, magnesium and caffeine. Brain Res. 585, 349-354.
84. Suzuki N., Cheung T. T., Cai X.-D., Odaka A., Otvos L. Jr., Eckman C., Golde T. E., and Younkin S. G. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264, 1336-1340.
85. Tamaoka A., Odaka A., Ishibashi Y., Usami M., Sahara N., Suzuki N., Nukina N., Mizusawa H., Shoji S., Kanazawa I., and Mori H. (1994a) APP717 missense mutation affects the ratio of amyloid β peptide species (Aβ1-42 and Aβ1-40) in familial Alzheimer's disease brain. J. Biol. Chem. 269, 32721-32724.
86. Tamaoka A., Kondo T., Odaka A., Sahara N., Sawamura N., Ozawa K., Suzuki N., Shoji S., and Mori H. (1994b) Biochemical evidence for the long-tail form of amyloid β protein as a seed molecule in cerebral deposits of Alzheimer's disease. Biochem. Biophys. Res. Commun. 205, 834-842.
87. Thastrup O., Cullen P., Drobak B., Hanley M., and Dawson A. (1990) Thapsigargin, a tumor promoter, discharges intracellular calcium stores by a specific inhibition of the endopasmic reticulum. Proc. Natl. Acad. Sci. USA 87, 2466-2470.
88. Tsuzuki K., Fukatsu R., Takamaru Y., Yoshida T., Mafune N., Kobayashi K., Fujii N., and Takahata N. (1995) Co-localization of amyloid-associated proteins with amyloid β in rat soleus muscle in chloroquine-induced myopathy. Brain Res. 699, 260-265.
89. Turner S., Suzuki N., Chyung A., Younkin S., and Lee V. (1996) Amyloids β40 and β42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271, 8966-8970.
90. 2+ transport. Neuroscience 49, 467-477.
91. 2+ stores in chicken Purkinje neurons. EMBO J. 10, 3183-3189.
92. Walter J., Capell A., Grunberg J., Pesold B., Schindzielorz A., Prior R., Podlisny M., Fraser P., Hyslop P. St. G., Selkoe D., and Haass C. (1996) The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2, 673-691.
93. Walton P. D., Airey J. A., Sutko J. L., Beck C. F., Mignery G. A., Sudhof T. C., Deerinck T. J., and Ellisman M. H. (1991) Ryanodine and inositol trisphosphate receptors coexist in avian cerebellar Purkinje neurons. J. Cell Biol. 113, 1145-1157.
94. Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J. M., Masters C. L., and Beyreuther K. (1989) Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126.
95. Weiss J. and Choi D. (1991) Differential vulnerability to excitatory amino acid-induced toxicity and selective neuronal loss in neurodegenerative diseases. Can. J. Neurol. Sci. 18, 394-397.
96. 2+-channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372-375.
97. Wrogemann K. and Pena S. D. J. (1976) Mitochondrial calcium overload: a general mechanism for cell necrosis in muscle diseases. Lancet i, 672-674.
98. Yamaguchi H., Yamazaki T., Lemere C. A., Frosch M. P., and Selkoe D. J. (1992) Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am. J. Pathol. 141, 249-259.
99. Yamaguchi H., Sugihara S., Ishiguro K., Takashima A., and Hirai S. (1995) Immunohistochemical analysis of COOH-termini of amyloid beta protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging. Amyloid: Int. J. Clin. Invest. 2, 7-16.
100. Yamazaki T., Selkoe D. J., and Koo E. H. (1995) Trafficking of cell surface β-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J. Cell Biol. 129, 431-442.
101. Yamazaki T., Koo E., and Selkoe D. (1996) Trafficking of cell-surface amyloid β-protein precursor II: endocytosis, recycling, and lysosomal targeting detected by immunolocalization. J. Cell Sci. 109, 999-1008.
102. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
103. +-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266, 17707-17712.
104. 2+ pools in PC12 cells. J Biol. Chem. 266, 20152-20158.